Charles River Laboratories International (CRL) Non-Current Debt (2009 - 2025)

Charles River Laboratories International's Non-Current Debt history runs 17 years deep, the most recent figure standing at $2.1 billion for Q4 2025.

• In Q4 2025, Non-Current Debt fell 4.64% year-over-year to $2.1 billion; the TTM figure through Dec 2025 stood at $2.1 billion (down 4.64% YoY), while the FY2025 annual figure was $2.1 billion, down 4.64% from the prior year.
• Non-Current Debt for Q4 2025 stood at $2.1 billion, down from $2.2 billion in the prior quarter.
• The five-year high for Non-Current Debt was $3.0 billion in Q2 2022, with the low at $2.1 billion in Q4 2025.
• The 5-year median for Non-Current Debt is $2.7 billion (2023), against an average of $2.6 billion.
• The sharpest annual moves came in 2021 and 2024: Non-Current Debt surged 38.04% in 2021, then dropped 15.37% in 2024.
• Charles River Laboratories International's Non-Current Debt stood at $2.7 billion in 2021, then gained by 1.65% to $2.7 billion in 2022, then slipped by 2.23% to $2.6 billion in 2023, then declined by 15.37% to $2.2 billion in 2024, then decreased by 4.64% to $2.1 billion in 2025.
• Business Quant data shows CRL's Non-Current Debt at $2.1 billion in Q4 2025, $2.2 billion in Q3 2025, and $2.3 billion in Q2 2025.